Thyrocare Technologies Q2FY26 net profit jumps 80% YoY; board approves bonus issue and interim dividend

Shares of Thyrocare Technologies closed in green on Tuesday ahead of its Q2FY26 results. The company reported strong performance across the board with a nearly 50% jump in Q2FY26 net profit.

In Q2FY26, the company’s revenue for the quarter jumped 23% YoY to ₹202 crore as compared to ₹163 crore in the previous year’s same quarter. While the revenue growth stood at 13% sequentially. The revenue growth was largely driven by its dom estic testing service, which grew by 24% YoY to ₹201 crore. The imaging service revenue stood unchanged at ₹14 crore.

In the previous quarter, the company recorded a fair growth of 24.55% in revenue, with ₹178 crore was reported in the June 2025 quarter as compared to ₹143 crore during the year-ago period. An average growth of 43.34% was recorded for the quarter ended June 2025 to ₹36 crore from ₹25 crore. Operating Profit saw a handsome growth to ₹60 crore from ₹45 crore in the quarter ended June 2025.

On the operational front, the company’s EBITDA for the quarter grew by 49% YoY to ₹75 crore . The EBITDA margins expanded to 34% from 30% in the previous year’s same quarter.

Lastly, the on a consolidated basis, net profit for the quarter jumped 82% YoY to ₹48 crore as against ₹26 crore. The bottom-line growth was aided by favourable tax adjustments during the quarter. Apart from the above notable parameters, the company also declared an interim dividend .

The company announced a ₹7 per share dividend on the face value of ₹10 per share with a record date of 24th October,2025. In addition, the board of directors also approved the issuance of bonus shares in the ratio of 2:1 for which the record date will be announced later.